
News
Here you will find financial news from APONTIS PHARMA as well as other publications relevant to the capital market.
Latest News
Corporate News
20.08.2025 | EQS-News
APONTIS PHARMA: Veränderungen im Vorstand
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA: Veränderungen im Vorstand 20.08.2025...
Ad-hoc News
13.06.2025 | EQS-Ad-hoc
APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40
APONTIS PHARMA AG/ Key word(s): Squeeze Out APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at...
Ad-hoc News
13.06.2025 |
APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40
APONTIS PHARMA AG / Key word(s): Squeeze Out APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at...
Corporate News
15.05.2025 | EQS-News
APONTIS PHARMA publishes results for the first quarter of 2025 and confirms forecast for 2025
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/Quarter Results APONTIS PHARMA publishes...
Corporate News
15.05.2025 |
APONTIS PHARMA veröffentlicht Ergebnisse des ersten Quartals 2025 und bestätigt Prognose 2025
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis APONTIS PHARMA...
Corporate News
31.03.2025 |
APONTIS PHARMA mit deutlichem Anstieg von Umsatz und Ergebnis im Geschäftsjahr 2024 – Squeeze-Out...
APONTIS PHARMA AG / Schlagwort(e): Jahresbericht/Jahresergebnis APONTIS PHARMA mit deutlichem Anstieg von...
Corporate News
31.03.2025 | EQS-News
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out...
EQS-News: APONTIS PHARMA AG/ Key word(s): Annual Report/Annual Results APONTIS PHARMA with significant sales and...
Ad-hoc News
05.03.2025 |
APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the...
APONTIS PHARMA AG / Key word(s): Squeeze Out APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a...
Ad-hoc News
05.03.2025 | EQS-Ad-hoc
APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the...
APONTIS PHARMA AG/ Key word(s): Squeeze Out APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a...
Directors' Dealings
11.12.2024 |
Thomas Milz
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
11.12.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, Sale: The sale was made via a joint custody account with Ariane...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Thomas Milz
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, Sale: The sale was made via a joint custody account with Ariane...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Karin Wohlschlegel
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Karin Wohlschlegel, sell
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
be executive GmbH
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: be executive GmbH, sell
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, sell
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Olaf Elbracht
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Olaf Elbracht, Sale: The sale was made via a joint securities account with...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Corporate News
21.11.2024 |
APONTIS PHARMA AG: Verzicht auf die Bedingung der Mindestannahme im freiwilligen öffentlichen...
APONTIS PHARMA AG / Schlagwort(e): Übernahmeangebot APONTIS PHARMA AG: Verzicht auf die Bedingung der...
Corporate News
21.11.2024 | EQS-News
APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
EQS-News: APONTIS PHARMA AG/ Key word(s): Tender Offer APONTIS PHARMA AG: Condition of Minimum Acceptance in...
Corporate News
07.11.2024 | EQS-News
APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue...
EQS-News: APONTIS PHARMA AG/ Key word(s): 9 Month figures/Change in Forecast APONTIS PHARMA reports profitable...
Corporate News
07.11.2024 |
APONTIS PHARMA mit profitablem Umsatzwachstum bei Single Pill-Kombinationen in 9M 2024 –...
APONTIS PHARMA AG / Schlagwort(e): 9-Monatszahlen/Prognoseänderung APONTIS PHARMA mit profitablem...
Corporate News
30.10.2024 | EQS-News
Management Board and Supervisory Board of APONTIS PHARMA AG recommend accepting Zentiva’s public...
EQS-News: APONTIS PHARMA AG/ Key word(s): Tender Offer/Statement Management Board and Supervisory Board of APONTIS...
Corporate News
30.10.2024 |
Vorstand und Aufsichtsrat der APONTIS PHARMA AG empfehlen Annahme des öffentlichen Erwerbsangebots...
APONTIS PHARMA AG / Schlagwort(e): Übernahmeangebot/Stellungnahme Vorstand und Aufsichtsrat der APONTIS...
Corporate News
16.10.2024 | EQS-News
APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a...
EQS-News: APONTIS PHARMA AG/ Key word(s): Tender Offer APONTIS PHARMA and Zentiva entered into partnership for...
Corporate News
16.10.2024 |
APONTIS PHARMA und Zentiva schließen Partnerschaft für zukünftiges Wachstum – Zentiva wird ein...
APONTIS PHARMA AG / Schlagwort(e): Übernahmeangebot APONTIS PHARMA und Zentiva schließen Partnerschaft für...
Ad-hoc News
16.10.2024 | EQS-Ad-hoc
APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public...
APONTIS PHARMA AG/ Key word(s): Tender Offer APONTIS PHARMA and Zentiva enter into investment agreement– Zentiva...
Ad-hoc News
16.10.2024 |
APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public...
APONTIS PHARMA AG / Key word(s): Tender Offer APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva...
Corporate News
09.08.2024 | EQS-News
APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of...
EQS-News: APONTIS PHARMA AG/ Key word(s): Half Year Report/Half Year Results APONTIS PHARMA with profitable revenue...
Corporate News
09.08.2024 |
APONTIS PHARMA mit profitablem Umsatzwachstum bei Single Pill-Kombinationen im ersten Halbjahr 2024...
APONTIS PHARMA AG / Schlagwort(e): Halbjahresbericht/Halbjahresergebnis APONTIS PHARMA mit profitablem...
Corporate News
27.06.2024 | EQS-News
APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the...
EQS-News: APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the...
Corporate News
27.06.2024 |
APONTIS PHARMA AG beruft mit Blick auf die strategische Weiterentwicklung des Unternehmens CFO...
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA AG beruft mit Blick auf die strategische...
Corporate News
04.06.2024 | EQS-News
APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned...
EQS-News: APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA continues to gear organization towards growth and...
Corporate News
04.06.2024 |
APONTIS PHARMA richtet Organisation weiter gezielt auf Wachstum und Internationalisierung aus –...
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA richtet Organisation weiter gezielt auf...
Directors' Dealings
14.05.2024 |
Thomas Milz
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
14.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
14.05.2024 |
be executive GmbH
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
14.05.2024 | EQS-DD
APONTIS PHARMA AG: be executive GmbH, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Corporate News
08.05.2024 | EQS-News
APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and...
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/Quarter Results APONTIS PHARMA starts...
Corporate News
08.05.2024 |
APONTIS PHARMA startet mit Umsatzwachstum bei Single Pill-Kombinationen und positivem Nettoergebnis...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis APONTIS PHARMA startet mit...
Corporate News
05.04.2024 | EQS-News
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma...
EQS-News: APONTIS PHARMA AG/ Key word(s): Change in Forecast/Alliance APONTIS PHARMA enters five-year distribution...
Corporate News
05.04.2024 |
APONTIS PHARMA schließt fünfjährige Distributions- und Vermarktungsvereinbarung für zwei...
APONTIS PHARMA AG / Schlagwort(e): Prognoseänderung/Kooperation APONTIS PHARMA schließt fünfjährige...
Ad-hoc News
05.04.2024 | EQS-Ad-hoc
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement...
APONTIS PHARMA AG/ Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG raises forecast after entering...
Ad-hoc News
05.04.2024 | EQS-Ad-hoc
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement...
APONTIS PHARMA AG / Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG raises forecast after entering...
Corporate News
28.03.2024 | EQS-News
APONTIS PHARMA expects profitable growth again in 2024
EQS-News: APONTIS PHARMA AG/ Key word(s): Annual Results/Annual Report APONTIS PHARMA expects profitable growth...
Corporate News
28.03.2024 |
APONTIS PHARMA erwartet 2024 wieder profitables Wachstum
APONTIS PHARMA AG / Schlagwort(e): Jahresergebnis/Jahresbericht APONTIS PHARMA erwartet 2024 wieder...
Corporate News
06.02.2024 |
APONTIS PHARMA schließt Performance- und Effizienzsteigerungsprogramm erfolgreich ab
APONTIS PHARMA AG / Schlagwort(e): Strategische Unternehmensentscheidung/Unternehmensrestrukturierung...
Corporate News
06.02.2024 | EQS-News
APONTIS PHARMA successfully completes performance and efficiency improvement program
EQS-News: APONTIS PHARMA AG/ Key word(s): Strategic Company Decision/Restructure of Company APONTIS PHARMA...
Corporate News
09.11.2023 |
APONTIS PHARMA stellt Details des Restrukturierungs- und Effizienzprogramms vor – Neun-Monatszahlen...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen APONTIS PHARMA stellt Details...
Corporate News
09.11.2023 | EQS-News
APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures...
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/9 Month figures APONTIS PHARMA presents...
Ad-hoc News
08.11.2023 | EQS-Ad-hoc
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
APONTIS PHARMA AG/ Key word(s): Strategic Company Decision/Restructure of Company APONTIS PHARMA AG with new...
Ad-hoc News
08.11.2023 |
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
APONTIS PHARMA AG / Key word(s): Strategic Company Decision/Restructure of Company APONTIS PHARMA AG with new...
Corporate News
10.08.2023 |
APONTIS PHARMA bestätigt vorläufige Zahlen – 1. Halbjahr 2023 mit Umsatz- und Ergebnisrückgängen
APONTIS PHARMA AG / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht APONTIS PHARMA bestätigt vorläufige...
Corporate News
10.08.2023 | EQS-News
APONTIS PHARMA confirms preliminary figures – H1 2023 sales and earnings decline
EQS-News: APONTIS PHARMA AG/ Key word(s): Half Year Results/Half Year Report APONTIS PHARMA confirms preliminary...
Ad-hoc News
31.07.2023 | EQS-Ad-hoc
APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024
APONTIS PHARMA AG/ Key word(s): Contract APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued...
Ad-hoc News
31.07.2023 |
APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024
APONTIS PHARMA AG / Key word(s): Contract APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be...
Corporate News
27.07.2023 |
APONTIS PHARMA AG nimmt Prognose für Geschäftsjahr 2023 sowie Mittelfristplanung für 2026 zurück –...
APONTIS PHARMA AG / Schlagwort(e): Prognoseänderung/Gewinnwarnung APONTIS PHARMA AG nimmt Prognose für...
Corporate News
27.07.2023 | EQS-News
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 –...
EQS-News: APONTIS PHARMA AG/ Key word(s): Change in Forecast/Profit Warning APONTIS PHARMA AG withdraws forecast for...
Ad-hoc News
27.07.2023 |
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026
APONTIS PHARMA AG / Key word(s): Change in Forecast/Profit Warning APONTIS PHARMA AG withdraws forecast for fiscal...
Ad-hoc News
27.07.2023 | EQS-Ad-hoc
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026
APONTIS PHARMA AG/ Key word(s): Change in Forecast/Profit Warning APONTIS PHARMA AG withdraws forecast for fiscal...
Corporate News
10.07.2023 |
APONTIS PHARMA: Vorstandsvorsitzender Karlheinz Gast legt Amt aus persönlichen Gründen nieder –...
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA: Vorstandsvorsitzender Karlheinz Gast legt Amt...
Corporate News
10.07.2023 | EQS-News
APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons - Bruno Wohlschlegel takes over as...
EQS-News: APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons-...
Ad-hoc News
10.07.2023 |
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
APONTIS PHARMA AG / Key word(s): Personnel APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal...
Ad-hoc News
10.07.2023 | EQS-Ad-hoc
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal...
Corporate News
29.06.2023 |
APONTIS PHARMA startet Single Pill Finder und Vertrieb für Single Pill Rosazimib – Erste von drei...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA startet Single Pill Finder und Vertrieb...
Corporate News
29.06.2023 | EQS-News
APONTIS PHARMA launches Single Pill Finder and distribution of Single Pill Rosazimib - First of...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA launches Single Pill Finder and distribution...
Corporate News
09.05.2023 | EQS-News
APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition...
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement APONTIS PHARMA in Q1 2023 records decline in...
Corporate News
09.05.2023 |
APONTIS PHARMA in Q1 2023 mit erwartetem Umsatz- und Ergebnisrückgang – 2023 als Übergangsjahr in...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung APONTIS PHARMA in Q1 2023 mit erwartetem...
Corporate News
08.05.2023 | EQS-News
APONTIS PHARMA: Keeping up high pace in expansion of Single Pill portfolio - New development...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA: Keeping up high pace in expansion of Single...
Corporate News
08.05.2023 |
APONTIS PHARMA: Anhaltend hohe Geschwindigkeit bei Ausbau des Single Pill-Portfolios — Neue...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA: Anhaltend hohe Geschwindigkeit bei...
Directors' Dealings
05.05.2023 |
Silke Reineke
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
05.05.2023 | EQS-DD
APONTIS PHARMA AG: Silke Reineke, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
05.05.2023 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
05.05.2023 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Ad-hoc News
02.05.2023 | EQS-Ad-hoc
APONTIS PHARMA AG adjusts forecast for fiscal year 2023
APONTIS PHARMA AG/ Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG adjusts forecast for fiscal year 2023...
Ad-hoc News
02.05.2023 |
APONTIS PHARMA AG adjusts forecast for fiscal year 2023
APONTIS PHARMA AG / Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG adjusts forecast for fiscal year...
Corporate News
27.04.2023 | EQS-News
APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA with first in-licensing of a Single Pill...
Corporate News
27.04.2023 |
APONTIS PHARMA mit erster Einlizenzierung einer Single Pill mit zwei Wirkstoffen zur...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA mit erster Einlizenzierung einer Single...
Corporate News
12.04.2023 |
APONTIS PHARMA: Neue Entwicklungspartnerschaft mit Midas Pharma – Erweiterung des Single...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA: Neue Entwicklungspartnerschaft mit...
Corporate News
12.04.2023 | EQS-News
APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA: New development partnership with Midas...
Corporate News
09.03.2023 |
APONTIS PHARMA mit erfolgreichem Geschäftsjahr 2022: Umsatz- und EBITDA-Prognose nach vorläufigen...
APONTIS PHARMA AG / Schlagwort(e): Vorläufiges Ergebnis/Jahresergebnis APONTIS PHARMA mit erfolgreichem...
Corporate News
09.03.2023 | EQS-News
APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded...
EQS-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Annual Results APONTIS PHARMA with successful...
Corporate News
14.02.2023 |
APONTIS PHARMA beschleunigt Ausbau des Single Pill-Portfolios mit zweiter von drei für 2023...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA beschleunigt Ausbau des Single...
Corporate News
14.02.2023 | EQS-News
APONTIS PHARMA accelerates expansion of Single Pill portfolio with second of three in-licensing...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA accelerates expansion of Single Pill...
Corporate News
31.01.2023 |
APONTIS PHARMA erweitert Portfolio zur Behandlung von Hypertonie und Hyperlipidämie durch...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA erweitert Portfolio zur Behandlung von...
Corporate News
31.01.2023 | EQS-News
APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA extends portfolio for the treatment of...
Corporate News
29.11.2022 |
APONTIS PHARMA: Anzahl der angekündigten Markteinführungen steigt auf zehn Single Pills – Portfolio...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA: Anzahl der angekündigten...
Corporate News
29.11.2022 | EQS-News
APONTIS PHARMA: Number of announced market launches increases to ten Single Pills – Portfolio grows...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA: Number of announced market launches...
Corporate News
10.11.2022 |
APONTIS PHARMA bestätigt Prognose 2022 nach erfolgreichem Neun-Monatszeitraum – Starke Single...
APONTIS PHARMA AG / Schlagwort(e): 9-Monatszahlen/Quartals-/Zwischenmitteilung APONTIS PHARMA bestätigt...
Corporate News
10.11.2022 | EQS-News
APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill...
EQS-News: APONTIS PHARMA AG/ Key word(s): 9 Month figures/Quarterly/ Interim Statement APONTIS PHARMA confirms 2022...
Corporate News
20.09.2022 |
APONTIS PHARMA gibt Kooperation zur Markteinführung einer neuen Single Pill in Deutschland bekannt
APONTIS PHARMA AG / Schlagwort(e): Kooperation/Produkteinführung APONTIS PHARMA gibt Kooperation zur...
Corporate News
20.09.2022 | EQS-News
APONTIS PHARMA announces cooperation to launch new Single Pill in Germany
EQS-News: APONTIS PHARMA AG/ Key word(s): Alliance/Product Launch APONTIS PHARMA announces cooperation to launch new...
Corporate News
01.09.2022 |
APONTIS PHARMA: SECURE-Studie und START-Studie-Zusatzanalyse bestätigen überlegene Wirksamkeit der...
APONTIS PHARMA AG / Schlagwort(e): Wissenschaftl. Publikation APONTIS PHARMA: SECURE-Studie und...
Corporate News
01.09.2022 | DGAP-News
APONTIS PHARMA: SECURE study and START study add-on analysis confirm superior efficacy of Single Pill
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication APONTIS PHARMA: SECURE study and START study...
Corporate News
11.08.2022 |
APONTIS PHARMA baut profitable Positionierung in H1 2022 aus – Prognose für Gesamtjahr bestätigt
APONTIS PHARMA AG / Schlagwort(e): Halbjahresbericht/Halbjahresergebnis APONTIS PHARMA baut profitable...
Corporate News
11.08.2022 | DGAP-News
APONTIS PHARMA expands profitable positioning in first half of 2022 – full-year forecast confirmed
DGAP-News: APONTIS PHARMA AG/ Key word(s): Half Year Report/Half Year Results APONTIS PHARMA expands profitable...
Corporate News
19.07.2022 |
APONTIS PHARMA und Midas Pharma vereinbaren weitere Entwicklungspartnerschaft zur Markteinführung...
APONTIS PHARMA AG / Schlagwort(e): Kooperation/Markteinführung APONTIS PHARMA und Midas Pharma vereinbaren...
Corporate News
19.07.2022 | DGAP-News
APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance/Market launch APONTIS PHARMA and Midas Pharma agree on further...
Corporate News
06.07.2022 |
APONTIS PHARMA führt eine neue Single Pill zur Sekundärprophylaxe in den Markt ein
APONTIS PHARMA AG / Schlagwort(e): Markteinführung APONTIS PHARMA führt eine neue Single Pill zur...
Corporate News
06.07.2022 | DGAP-News
APONTIS PHARMA rolls out new Single Pill for secondary prophylaxis
DGAP-News: APONTIS PHARMA AG/ Key word(s): Market launch APONTIS PHARMA rolls out new Single Pill for secondary...
Corporate News
23.06.2022 | DGAP-News
APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG/ Key word(s): Share Buyback APONTIS PHARMA AG: Notice according to Article 2 paragraph...
Corporate News
23.06.2022 |
APONTIS PHARMA AG: Bekanntmachung gemäß Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052
APONTIS PHARMA AG / Schlagwort(e): Aktienrückkauf APONTIS PHARMA AG: Bekanntmachung gemäß Art. 2 Abs. 1 der...
Corporate News
25.05.2022 | DGAP-News
APONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA launches two new single pills- medium-term...
Corporate News
25.05.2022 |
APONTIS PHARMA führt zwei neue Single Pills in den Markt ein – mittelfristiges Umsatzpotenzial von...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA führt zwei neue Single Pills in den...
Corporate News
12.05.2022 | DGAP-News
APONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large...
DGAP-News: APONTIS PHARMA AG/ Key word(s): AGM/EGM APONTIS PHARMA holds Annual General Meeting 2022- shareholders...
Corporate News
12.05.2022 | DGAP-News
APONTIS PHARMA führt ordentliche Hauptversammlung 2022 durch – Aktionäre stimmen allen...
APONTIS PHARMA AG / Schlagwort(e): Hauptversammlung APONTIS PHARMA führt ordentliche Hauptversammlung 2022...
Corporate News
10.05.2022 |
APONTIS PHARMA mit anhaltend starkem profitablem Wachstum im ersten Quartal 2022
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung APONTIS PHARMA mit anhaltend starkem...
Corporate News
10.05.2022 | DGAP-News
APONTIS PHARMA continues strong profitable growth in Q1 2022
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement APONTIS PHARMA continues strong profitable...
Corporate News
05.05.2022 |
APONTIS PHARMA und Develco Pharma schließen Entwicklungspartnerschaft zur Markteinführung zweier...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA und Develco Pharma schließen...
Corporate News
05.05.2022 | DGAP-News
APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA and Develco Pharma enter development...
Corporate News
20.04.2022 |
APONTIS PHARMA: START-Studie in wissenschaftlicher Publikation veröffentlicht - Kostenreduktion in...
APONTIS PHARMA AG / Schlagwort(e): Wissenschaftl. Publikation APONTIS PHARMA: START-Studie in...
Corporate News
20.04.2022 | DGAP-News
APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication APONTIS PHARMA: START study published in...
Corporate News
16.03.2022 |
APONTIS PHARMA: START-Studie in wissenschaftlicher Publikation veröffentlicht - Geringeres...
APONTIS PHARMA AG / Schlagwort(e): Wissenschaftl. Publikation APONTIS PHARMA: START-Studie in...
Corporate News
16.03.2022 | DGAP-News
APONTIS PHARMA: START study published in scientific journal - Lower incidence of cardiovascular...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication 16.03.2022/ 07:30 The issuer is solely responsible...
Corporate News
15.03.2022 |
APONTIS PHARMA AG: Bekanntmachung gemäß Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052
APONTIS PHARMA AG / Schlagwort(e): Aktienrückkauf APONTIS PHARMA AG: Bekanntmachung gemäß Art. 2 Abs. 1 der...
Corporate News
15.03.2022 | DGAP-News
APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG/ Key word(s): Share Buyback 15.03.2022/ 07:30 The issuer is solely responsible for the...
Corporate News
08.03.2022 |
APONTIS PHARMA und AstraZeneca verlängern strategische Vertriebskooperation
APONTIS PHARMA AG / Schlagwort(e): Kooperation APONTIS PHARMA und AstraZeneca verlängern strategische...
Corporate News
08.03.2022 | DGAP-News
APONTIS PHARMA and AstraZeneca extend strategic sales cooperation
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance 08.03.2022/ 07:30 The issuer is solely responsible for the...
Corporate News
03.03.2022 |
APONTIS PHARMA mit erfolgreichem Geschäftsjahr 2021 - Single Pills als Wachstumstreiber
APONTIS PHARMA AG / Schlagwort(e): Vorläufiges Ergebnis/Jahresergebnis APONTIS PHARMA mit erfolgreichem...
Corporate News
03.03.2022 | DGAP-News
APONTIS PHARMA reports successful financial year 2021 - Single Pills as growth driver
DGAP-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Annual Results 03.03.2022/ 07:30 The issuer is solely...
Corporate News
16.12.2021 |
APONTIS PHARMA erweitert Management für künftiges Wachstum: Thomas Zimmermann wird neuer CFO
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA erweitert Management für künftiges Wachstum:...
Corporate News
16.12.2021 | DGAP-News
APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA AG/ Key word(s): Personnel 16.12.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
14.12.2021 |
APONTIS PHARMA und Midas Pharma geben Entwicklungspartnerschaft zur Markteinführung einer Single...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung/Kooperation APONTIS PHARMA und Midas Pharma geben...
Corporate News
14.12.2021 | DGAP-News
APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch/Alliance 14.12.2021/ 07:30 The issuer is solely...
Corporate News
18.11.2021 |
APONTIS PHARMA wächst im 9-Monatszeitraum 2021 deutlich schneller als der Gesamtmarkt -...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen APONTIS PHARMA wächst im...
Corporate News
18.11.2021 | DGAP-News
APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 -...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/9 Month figures 18.11.2021/ 07:30 The issuer...
Corporate News
26.10.2021 |
APONTIS PHARMA gibt Markteinführung einer neuen Single Pill bekannt
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA gibt Markteinführung einer neuen Single...
Corporate News
26.10.2021 | DGAP-News
APONTIS PHARMA announces market launch of new Single Pill
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch 26.10.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
14.09.2021 |
APONTIS PHARMA gibt Markteinführung einer neuen Single Pill zur effizienteren Behandlung von...
APONTIS PHARMA AG / Schlagwort(e): Produkteinführung APONTIS PHARMA gibt Markteinführung einer neuen Single...
Corporate News
14.09.2021 | DGAP-News
APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch 14.09.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
11.08.2021 |
APONTIS PHARMA baut starke Position und Profitabilität in H1 2021 aus - Vorläufige Zahlen und...
APONTIS PHARMA AG / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht APONTIS PHARMA baut starke Position...
Corporate News
11.08.2021 | DGAP-News
APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Half Year Results/Half Year Report 11.08.2021/ 07:30 The issuer is solely...
Corporate News
28.07.2021 | DGAP-News
APONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Half Year Results 28.07.2021/ 07:30 The issuer is...
Corporate News
28.07.2021 |
APONTIS PHARMA mit beschleunigtem Wachstum in H1 2021 - Umsatz mit Single Pills +83 % auf EUR 14,0...
APONTIS PHARMA AG / Schlagwort(e): Vorläufiges Ergebnis/Halbjahresergebnis APONTIS PHARMA mit beschleunigtem...
Corporate News
12.07.2021 | DGAP-News
APONTIS PHARMA marks further success in the roll-out of Single Pill therapy
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance 12.07.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
12.07.2021 |
APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie
APONTIS PHARMA AG / Schlagwort(e): Kooperation APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der...
Corporate News
18.06.2021 | DGAP-News
APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Research Update 18.06.2021/ 07:30 The issuer is solely responsible for...
Corporate News
18.06.2021 |
APONTIS PHARMA AG: Initial-Studien bescheinigen der Aktie zwischen 77 % und 135 % Kurspotenzial
APONTIS PHARMA AG / Schlagwort(e): Research Update APONTIS PHARMA AG: Initial-Studien bescheinigen der Aktie...
Corporate News
10.06.2021 |
APONTIS PHARMA AG: Post-Stabilisierungsmitteilung - Teilweise Ausübung der Greenshoe-Option
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Post-Stabilisierungsmitteilung - Teilweise...
Corporate News
10.06.2021 | DGAP-News
APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 10.06.2021/ 21:23 The issuer is solely responsible for the...
Corporate News
10.06.2021 |
APONTIS PHARMA AG: Bekanntmachung über die Durchführung von Stabilisierungsmaßnahmen
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Bekanntmachung über die Durchführung von...
Corporate News
10.06.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 10.06.2021/ 21:20 The issuer is solely responsible for the...
Corporate News
28.05.2021 |
APONTIS PHARMA AG: Bekanntmachung über die Durchführung von Stabilisierungsmaßnahmen
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Bekanntmachung über die Durchführung von...
Corporate News
28.05.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 28.05.2021/ 20:05 The issuer is solely responsible for the...
Corporate News
20.05.2021 |
APONTIS PHARMA AG Trading Update: Starkes Umsatz- und Ergebniswachstum mit Single Pills setzt sich...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung APONTIS PHARMA AG Trading Update: Starkes...
Corporate News
20.05.2021 | DGAP-News
APONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement 20.05.2021/ 07:30 The issuer is solely...
Corporate News
19.05.2021 |
APONTIS PHARMA AG: Bekanntmachung über die Durchführung von Stabilisierungsmaßnahmen
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Bekanntmachung über die Durchführung von...
Corporate News
19.05.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 19.05.2021/ 20:23 The issuer is solely responsible for the...
Corporate News
14.05.2021 | EQS-News
Apontis Pharma (APPH): Initiation - A phoenix rises
Edison Investment Research Limited 14-May-2021/ 07:00 GMT/BST London, UK, 14 May 2021 Apontis...
Corporate News
06.05.2021 | DGAP-News
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 06.05.2021/ 20:09 The issuer is solely responsible for the content of...
Corporate News
06.05.2021 |
APONTIS PHARMA AG legt Platzierungspreis für ihren Börsengang auf EUR 19,00 je Aktie fest
APONTIS PHARMA AG / Schlagwort(e): Börsengang APONTIS PHARMA AG legt Platzierungspreis für ihren Börsengang...
Ad-hoc News
06.05.2021 |
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
APONTIS PHARMA AG / Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share...
Ad-hoc News
06.05.2021 | DGAP-Ad-hoc
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
APONTIS PHARMA AG/ Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share...
Corporate News
29.04.2021 | DGAP-News
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 29.04.2021/ 08:30 The issuer is solely responsible for the content of...
Corporate News
29.04.2021 |
APONTIS PHARMA AG legt Preisspanne für geplanten Börsengang auf EUR 18,50 bis EUR 24,50 je Aktie fest
APONTIS PHARMA AG / Schlagwort(e): Börsengang APONTIS PHARMA AG legt Preisspanne für geplanten Börsengang...
Corporate News
21.04.2021 | DGAP-News
APONTIS PHARMA plans initial public offering
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 21.04.2021/ 08:30 The issuer is solely responsible for the content of...
Corporate News
21.04.2021 |
APONTIS PHARMA plant Börsengang
APONTIS PHARMA AG / Schlagwort(e): Börsengang APONTIS PHARMA plant Börsengang 21.04.2021 / 08:30...
Sven Pauly
Thank you very much,
we have received your message
and will contact you shortly!
we have received your message
and will contact you shortly!